Manchester's The Christie — one of Europe's leading cancer centres — and Manchester Royal Infirmary manage substantial numbers of Chronic Myeloid Leukaemia (CML) patients on long-term tyrosine kinase inhibitor therapy. Imatib 400mg, the Indian generic of Glivec, provides identical treatment at significantly reduced cost for those requiring supply outside NHS channels.
Imatib contains Imatinib Mesylate 400mg, targeting the BCR-ABL fusion protein created by the Philadelphia chromosome, which drives CML development. Since its introduction, Imatinib has transformed CML from a fatal leukaemia into a manageable chronic condition, with most patients achieving complete cytogenetic remission and near-normal life expectancy with continued therapy.
Imatib is also widely used for Gastrointestinal Stromal Tumours (GIST), targeting mutated KIT and PDGFRA receptors. Manchester patients accessing private haematology or requiring international supply can access generic Imatib with full WHO-GMP certification. Visit medshopy.com or WhatsApp +91 82650 41513.
Imatib contains Imatinib Mesylate 400mg, targeting the BCR-ABL fusion protein created by the Philadelphia chromosome, which drives CML development. Since its introduction, Imatinib has transformed CML from a fatal leukaemia into a manageable chronic condition, with most patients achieving complete cytogenetic remission and near-normal life expectancy with continued therapy.
Imatib is also widely used for Gastrointestinal Stromal Tumours (GIST), targeting mutated KIT and PDGFRA receptors. Manchester patients accessing private haematology or requiring international supply can access generic Imatib with full WHO-GMP certification. Visit medshopy.com or WhatsApp +91 82650 41513.